INTERNATIONAL PATENT: SHANGHAI HANSOH BIOMEDICAL CO., LTD., 上海翰森生物医药科技有限公司, JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD., 江苏豪森药业集团有限公司 FILES APPLICATION FOR "USE OF NEW-GENERATION EGFR INHIBITOR SINGLE DRUG OR COMBINATION THEREOF IN PREPARING DRUGS FOR TUMOR DISEASES"

GENEVA, March 24 -- SHANGHAI HANSOH BIOMEDICAL CO., LTD. (Building 11, No.3728 Jinke Road, (Shanghai) Pilot Free Trade Zone,Pudong New Area, Shanghai 201203), 上海翰森生物医药科技有限公司 (中国上海市浦东新区（上海）自由贸易试验区金科路3728号11幢), JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏豪森药业集团有限公司 (中国江苏省连&...